Der Kaninchen Polyklonal anti-MEGF8 Antikörper wird verwendet zum Nachweis von MEGF8 in Proben von Human, Maus und Ratte. Er wurde validiert für ELISA, WB, IHC und IF.
MEGF8
Reaktivität: Human
WB, ICC
Wirt: Maus
Monoclonal
7-D4
unconjugated
Applikationshinweise
Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-1:2000,IHC 1:100-1:300,ELISA 1:20000,IF 1:50-200
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
1 mg/mL
Buffer
Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
-20 °C
Informationen zur Lagerung
Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
Haltbarkeit
12 months
Target
MEGF8
(Multiple EGF-Like-Domains 8 (MEGF8))
Andere Bezeichnung
EGFL4
Hintergrund
MEGF8, C19orf49, EGFL4, KIAA0817, Multiple epidermal growth factor-like domains protein 8, Multiple EGF-like domains protein 8, Epidermal growth factor-like protein 4, EGF-like protein 4Multiple EGF like domains 8 encoded by MEGF8 is a single-pass type I membrane protein of unknown function that contains several EGF-like domains, Kelch repeats, and PSI domains. Defects in MEGF8 are a cause of Carpenter syndrome 2. Two transcript variants encoding different isoforms have been found for MEGF8.